comparemela.com
  1. Home
  2. Live Updates
  3. Advanced Pancreatic Cancer Patients - Breaking News

Latest Breaking News On - Advanced pancreatic cancer patients - Page 1 : comparemela.com

NGM Bio Presents Updated Preliminary Findings from the Ongoing Phase 1b Dose Escalation Trial of NGM120 in Combination with Gemcitabine and Nab-paclitaxel in Patients with Metastatic Pancreatic Cancer at AACR Special Conference: Pancreatic Cancer

NGM120 is a novel antagonist antibody that binds GFRAL and inhibits GDF15 signaling for the potential treatment of cancerNGM120 has been well tolerated to date in patients in the Phase 1b combination. | September 13, 2022

United statesAndrew hendifarAlex depaoliBiopharmaceuticals incExchange commissionAmerican association for cancer researchSamuel oschin cancer centerAmerican associationCancer researchSpecial conferencePancreatic cancerAdvanced pancreatic cancer patientsReceptor alpha likeSenior vice presidentChief translational officerPrivate securities litigation reform act

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.